Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Celgene's Abraxane Under Fire in NEJM Letter
Celgene's Abraxane Under Fire in NEJM Letter
Celgene's Abraxane Under Fire in NEJM Letter
Submitted by
admin
on January 30, 2014 - 10:10am
Source:
TheStreet.com
News Tags:
New England Journal of Medicine
Abraxane
Celgene
pancreatic cancer
breast cancer
lung cancer
Headline:
Celgene's Abraxane Under Fire in NEJM Letter
Do Not Allow Advertisers to Use My Personal information
